Metabolic Medicine

Based within @UofGSCMH @UofGMVLS @UofGlasgow
we conduct research into the mechanisms, prevention and treatment of diabetes, cardiovascular disease, and obesity

[Metabolic Medicine @MetaMedTeam]

We have new accounts on Bluesky for Prof Naveed Sattar @ https://t.co/9cHIqPUOoe and team @ https://t.co/BewsP3kDWl, if you’d like to follow us there 😊

[Metabolic Medicine @MetaMedTeam]

Dr Lyn Ferguson @lyndferguson on Managing obesity and related multiple long-term conditions in modern medicine at Royal College of Physicians annual Medicine 2026 conference https://t.co/wfNH0dpkqI

[Metabolic Medicine @MetaMedTeam]

Prof Naveed Sattar has been awarded the 2026 Outstanding Achievement in Clinical Diabetes Research Award and will collect his award at a ceremony at the ADA 85th Scientific Sessions in New Orleans in June 2026 @ https://t.co/9cHIqPUgyG @ https://t.co/BewsP3k66N

[American Diabetes Association - DiabetesPro @ADA_DiabetesPro]

🎉 We’re pleased to announce the 2026 National Scientific and Health Care Achievement Award winners! The awards honor academics, clinicians, and educators who have contributed to substantial advances in diabetes care and research. Learn more at https://t.co/9zD8d98Xq0.

[Metabolic Medicine @MetaMedTeam]

Webinar for healthcare professionals: Obesity Specialist Group - Obesity, Risk Modification and Incretin Insights: Shaping Future Care Strategies, with speaker Prof Naveed Sattar, 12pm–1.15pm GMT 22nd Jan 2026 https://t.co/gFVaup6sxh

[Metabolic Medicine @MetaMedTeam]

An interesting finding that may enrich the ‘weight therapy vs NT-proBNP change’ debate. Interesting to see what the CV community make of it https://t.co/mnBWVvSRT1

[UofG News @UofGNews]

.@UofGlasgow’s Professor Naveed Sattar speaks to @BBCFergusWalsh in @BBCPanorama this week about the potential of weight loss jabs for improving health and the current issues around access to them.
@UofGSCMH @UofGMVLS

[UofG School of Health & Wellbeing @UofGSHW]

The number of important routine health measurements – particularly blood pressure checks - taking place since the pandemic has substantially reduced in England, with implications for missed diagnosis and increased health inequalities.

Read more➡️
https://t.co/9OLnM2x3VY

[Janice Richardson @janicericha2023]

We are still looking for volunteers ✨

[Metabolic Medicine @MetaMedTeam]

Understanding why Type 2 diabetes may be going up in younger people and what the best future treatment potentials are. A Scottish perspective

[UofG MVLS @UofGMVLS]

🆕 “A primary focus on weight and related lifestyle factors must be the key to future management of younger onset type 2 diabetes…”

Read the new article on type 2 diabetes by @UofGlasgow’s Prof Naveed Sattar in @TheLancetEndo 🩺

@UofGSCMH
https://t.co/qczrgK3onn

[UofG MVLS @UofGMVLS]

Our #FuturesFellowships scheme is open for applications!

The 5-year Fellowship scheme represents our commitment to nurture talent and foster the next generation of leaders in their chosen field.

Professor Iain McInnes explains more 🌟

Apply https://t.co/3Z85krWljB

#MVLS2033

[PACE-CME @PACEcme]

Obesity: A looming cardiovascular threat

Naveed Sattar explains the relationship between adiposity and CVD by presenting evidence from epidemiological studies, genetic data, pathways to ASCVD and weight loss studies.

Watch: https://t.co/AFfOJ8P0HO #obesity #CVD #CardioTwitter

[Metabolic Medicine @MetaMedTeam]

This article by Prof Naveed Sattar et al attempts to explain potential gains of semaglutide (and potentially other newer anti-obesity medicines to come) in the cardiometabolic/kidney space https://t.co/GZieqNkoM2 @UofGSCMH @matthewmylee

[Diabetes UK Research @DUK_research]

📢Today we're launching our two new funding schemes, calling for future Black Leaders in #Diabetes. By fostering diversity in the #research community, we hope to include and nurture underrepresented voices and talents.🧑🏿‍🔬 1/5

[Metabolic Medicine @MetaMedTeam]

This paper, from Prof Naveed Sattar et al, gives a topline view on how #obesity impacts the #cardiovascular space. Hope you enjoy reading it and find it somewhat useful @CircAHA @UofGSCMH @UofGMVLS https://t.co/Qnqcdt0YXf

[Metabolic Medicine @MetaMedTeam]

We are still looking for a few more volunteers. Can you help?

[Metabolic Medicine @MetaMedTeam]

*Currently Recruiting*

If you are a South Asian male aged between 30-65 years old, you may be able to help us!

[Metabolic Medicine @MetaMedTeam]

Congratulations @JasonGill74 🥳🍾

[Royal Society of Edinburgh @RoyalSocEd]

Meet our newest Fellows.

We are honoured to announce the 57 leading thinkers from the sciences, arts, education, business, and public life have been elected to our Fellowship for 2024. We look forward to working with them for the betterment of society.

https://t.co/CZh8lCwP6o

[Matthew MY Lee @matthewmylee]

Appetite and its regulation: are there palatable interventions for heart failure?

We summarise key reported and ongoing randomized clinical trials of appetite regulation and/or dietary energy restriction in HF.

@MEJLean NaveedSattar @markcpetrie20

https://t.co/9vDQtf1NM9

[Metabolic Medicine @MetaMedTeam]

Prof Naveed Sattar and colleagues explain how obesity influences complications in patients with type 2 diabetes in more ways than previously realised @DiabetesCareADA @UofGSCMH https://t.co/WoMFpACydP

[UofG SCMH @UofGSCMH]

New Paper in @Clin_Chem_ADLM from Professor Paul Welsh et al on Multiple Cardiac Biomarkers to Improve Prediction of Cardiovascular Events: Findings from the Generation Scotland Scottish Family Health Study.
@UofGMVLS @MetaMedTeam

Find out more ⬇

[UofG MVLS @UofGMVLS]

🆕 findings from an extension of the landmark Diabetes Remission Clinical Trial DiRECT reveal that, for those in remission from #type2diabetes at the end of year two of the original study, 26% still remained in remission at year five.

More 👉 https://t.co/U6spWIQEcP